Contraceptive discontinuation in urban Honduras Janine Barden-O’Fallon, PhD Ilene Speizer, PhD University of North Carolina at Chapel Hill, USA 29 September.

Slides:



Advertisements
Similar presentations
DATA DEMAND AND USE: S HARING I NFORMATION AND P ROVIDING F EEDBACK Session 5.
Advertisements

Nigeria Case Study HIVAIDS Specific Slides. ANALYZING AND INTERPRETING DATA.
Rwanda Case Study Additional Slides on Stakeholder Involvement.
Goal 5: Improve maternal health Target 5b: Achieve, by 2015, universal access to reproductive health 5.3 Contraceptive prevalence rate 5.4 Adolescent birth.
Demand for family planning among postpartum women attending integrated HIV and postnatal services in Swaziland Charlotte Warren, Timothy Abuya, Ian Askew,
GENERATING DEMAND FOR DATA Module 1. Session Objectives  Understand the importance of improving data-informed decision making  Understand the role of.
Understanding the role of child marriage on reproductive health outcomes: evidence from a multi- country study in South Asia Deepali Godha, David Hotchkiss,
Is There a Causal Relationship Between Maternal Health Care Utilization and Subsequent Contraceptive Use?: Evidence from Kenya and Zambia Mai Do and David.
Begin with the End in Mind
What characteristics differentiate method switchers from discontinuers? Janine Barden-O’Fallon, PhD Ilene Speizer, PhD University of North Carolina at.
Women’s empowerment and choice of family planning methods Mai Do and Nami Kurimoto Department of International Health and Development Tulane University.
LINKING DATA TO ACTION Session 6. Session Objectives By the end of this session, you will be able to:  Identify priority decisions and programmatic questions.
Dissemination and Use of Results from OVC Program Evaluations Florence Nyangara, PhD MEASURE Evaluation/Futures Group Dissemination Meeting, September.
DETERMINANTS OF DATA USE Session 2. Session Objectives  Explain the data-use conceptual framework  Highlight the determinants of data use  List potential.
UNDERSTANDING DATA AND INFORMATION FLOW Session 4.
Fertility management options for women in Azerbaijan November 2006 Boston, MA Annual APHA Conference Nabat Mursagulova, M.D. Monitoring & Evaluation Advisor.
Understanding patterns of temporary method use among urban Indian women Janine Barden-O’Fallon, MEASURE Evaluation PRH Lisa Calhoun, MLE Livia Montana,
MEASURE Evaluation DATIM Data Exchange Denise Johnson
Together for Health is funded by the United States Agency for International Development and implemented by JSI Research & Training Institute, Inc. in collaboration.
Business as Unusual: Changing the Approach to Monitoring OVC Programs Karen G. Fleischman Foreit, PhD Futures Group/MEASURE Evaluation.
Background Study Objectives Poster No. B50 Track 2  Family planning affects women’s health and lives, and depends on a variety of socio-demographic and.
Case management versus M&E in the context of OVC programs: What have we learned? Jenifer Chapman, PhD Futures Group/MEASURE Evaluation.
Bridging the Research-to-Practice Gap Session 1. Session Objectives  Understand the importance of improving data- informed decision making  Understand.
PLACE Method Priorities for Local AIDS Control Efforts 1 1 MEASURE Evaluation, A Manual for implementing the PLACE Method.
Evaluations of MSI’s Mobile Outreach Services in India and Zimbabwe Ian Askew Population Council.
Linking Data with Action Part 1: Seven Steps of Using Information for Decision Making.
Linking Data with Action Part 2: Understanding Data Discrepancies.
Integrating variant channels in engaging “life-stage” audiences to make informed Family Planning choices in Uganda Sylvia Mariettah.N. Katende 1, Kim Case.
Men as Partners: Reaching Influencers Mame Niang, MD, MPH September 18, 2015.
Regional Forum: Use of Gender Data in Sub-national Decision-making Kigali, Rwanda August 2012 Key Gender Terms and Concepts.
Data Use for Gender-Aware Health Programming Session 1: Setting the Gender Policy Context.
Unmet Need Exercise  Review the trends in CPR. What do you conclude about the performance of the FP program in each country?  Review trends in unmet.
Day 4: Field Practicum This presentation has been supported by the U.S President’s Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for.
MEASURE EVALUATION Session: 7 Developing Action Plans Based on Results Data Quality Assurance Workshop.
MER Essential Survey Indicators Jenifer Chapman, PhD & Lisa Parker, PhD February 2, 2015.
Data Use for Gender-Aware Health Programming Welcome and Introductions.
Monitoring & Evaluation Capacity Strengthening Workshop WORKSHOP INTRODUCTION AND OVERVIEW.
Integration of Community Based Services It seems like a good idea, but how to make it work? Molly Cannon Palladium/MEASURE Evaluation September 28, 2015.
Introduction ROUTINE HEALTH INFORMATION SYSTEMS MODULE 9:
Difference-in-Differences Models
Data Quality Assurance Workshop
Introduction MODULE 2: Indicators and Data Collection and Reporting
Introduction ROUTINE HEALTH INFORMATION SYSTEMS MODULE 5:
Session: 5 Using the RDQA tool for System Assessment
Community Health Information System in Action in SNNPR/Ethiopia
Introduction MODULE 6: RHIS Data Demand and Use
Contraceptive Trends Among Women at Reproductive Age
The PLACE Mapping Tool Becky Wilkes, MS, GISP Marc Peterson, MA, GISP
Training of Trainers on the OVC Household Vulnerability Prioritization Tool.
Measuring Success Toolkit
MEASURE Evaluation Using a Primary Health Care Lens Gabriela Escudero
Aparna Jain, PhD, MPH Laura Reichenbach, PhD
Introduction ROUTINE HEALTH INFORMATION SYSTEMS MODULE 4:
Session: 4 Using the RDQA tool for Data Verification
Community Health Information System in Action in SNNPR/Ethiopia
Training Content and Orientation
Introduction ROUTINE HEALTH INFORMATION SYSTEMS MODULE 3:
Introduction to Health Informatics:
Information Systems for Health:
Process Improvement, System Design, and Usability Evaluation
Information Systems for Health:
Introduction to Health Informatics:
Introduction MODULE 7: RHIS Governance and Management of Resources
Process Improvement, System Design, and Usability Evaluation
Siân Curtis, PhD OVC Evaluation Dissemination Meeting,
Data and Interoperability:
Introduction to Health Informatics
Session: 9 On-going Monitoring & Follow Up
Process Improvement, System Design, and Usability Evaluation
Willis Odek, PhD Chief of Party/Senior Technical Advisor,
Presentation transcript:

Contraceptive discontinuation in urban Honduras Janine Barden-O’Fallon, PhD Ilene Speizer, PhD University of North Carolina at Chapel Hill, USA 29 September 2009

Overview Results from a one-year follow-up study with reversible method users conducted in Honduras, The study was funded by USAID and implemented by MEASURE Evaluation in collaboration with Programas para el Desarollo de Infantes y Mujeres (PRODIM)

Contraceptive Discontinuation  Common, though varies by country  Most common during first 12 months of use  Contributes to unmet need  Can lead to unplanned pregnancy and unwanted births, resulting in negative public health outcomes

Objective  To determine how multiple factors affect contraceptive discontinuation among users of temporary methods over a one-year period  Demographic characteristics  Fertility motivations  Partner engagement  Quality of FP services  Experience of side effects  Method characteristics

Study Sites

Data: Panel study collected in 2 rounds  Baseline exit interviews with 800 women aged 15-44, attending a FP appointment in selected health facilities in which they received the injectable, IUD, or oral contraceptive pill  Women were both new and continuing users  There were no quotas by type of method  Follow-up interviews completed with 671 (84%) 1 year later

Study sample at baseline (n=671)  Young (94% under age 35)  Educated (30% reached secondary or higher)  Parity >/= 1  Married/in union (89%)  Urban residents (77%)  Desire to space a birth 2+ years (50%) or no more children (34%)

Method use by status of user at Baseline; N=671

Discontinuation Rate of Baseline Method, N= 324 Baseline 6 12 months Injectable IUD Pills TOTAL Results: Discontinuation was common…

Transition to First Episode of Non-Use, N= 324 Baseline 6 12 months Injectable IUD Pills TOTAL …But many switched to another method

Multivariate analysis: Cox proportional hazards models  Model 1: Time until discontinuation of baseline method  Model 2: Time until first episode of non-use of any method (Model 2)  Covariates: demographic characteristics, fertility motivations and family engagement, experience of side effects, baseline service quality, and user status at baseline  Stratified by baseline method

Demographic characteristics ** ***

Fertility motivations & family engagement * **

Experience with side effects

Service quality *

Discussion  More than 4 out of 10 women discontinued the baseline method  Living in rural areas may limit ability to successfully switch methods  Service quality had little effect on discontinuation  Family and friends may support continuation

MEASURE Evaluation is funded by the U.S. Agency for International Development and is implemented by the Carolina Population Center at the University of North Carolina at Chapel Hill in partnership with Futures Group International, ICF Macro, John Snow, Inc., Management Sciences for Health, and Tulane University. The views expressed in this presentation do not necessarily reflect the views of USAID or the United States Government. Thank you